|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2007-2-8
|
|
pubmed:abstractText |
Liver transplantation has evolved as a successful treatment for patients with end-stage liver cirrhosis and acute liver failure. Postoperative survival rates have increased to 90% in 1 year and 80% in 5 years as a result of improvements in immunosuppression, perioperative management and surgical techniques. However, a wide range of postoperative complications are of technical or medical origin. This study was undertaken to determine the relationship between the technical improvements and optimal timing of surgery and its outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1499-3872
|
|
pubmed:author |
pubmed-author:CaiQiu-ChengQC,
pubmed-author:ChenYong-BiaoYB,
pubmed-author:DewL LLL,
pubmed-author:HuHuan-ZhangHZ,
pubmed-author:JiangYiY,
pubmed-author:LvLi-ZhiLZ,
pubmed-author:WeiWei-MingWM,
pubmed-author:YangFangF,
pubmed-author:ZhangKunK,
pubmed-author:ZhangShao-GengSG,
pubmed-author:ZhangXiao-JinXJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
6
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
24-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17287161-Adult,
pubmed-meshheading:17287161-Aged,
pubmed-meshheading:17287161-Female,
pubmed-meshheading:17287161-Humans,
pubmed-meshheading:17287161-Liver, Artificial,
pubmed-meshheading:17287161-Liver Diseases,
pubmed-meshheading:17287161-Liver Neoplasms,
pubmed-meshheading:17287161-Liver Transplantation,
pubmed-meshheading:17287161-Male,
pubmed-meshheading:17287161-Middle Aged,
pubmed-meshheading:17287161-Prognosis
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Liver transplant for 70 patients with end-stage liver diseases.
|
|
pubmed:affiliation |
Centre of Hepatobiliary Surgery, Fuzhou General Hospital, Fuzhou 350025, China. jiangyi183@yahoo.com.cn
|
|
pubmed:publicationType |
Journal Article
|
